293 related articles for article (PubMed ID: 27996095)
1. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
Teymouri M; Barati N; Pirro M; Sahebkar A
J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
[TBL] [Abstract][Full Text] [Related]
2. Differential antioxidant/pro-oxidant activity of dimethoxycurcumin, a synthetic analogue of curcumin.
Kunwar A; Barik A; Sandur SK; Indira Priyadarsini K
Free Radic Res; 2011 Aug; 45(8):959-65. PubMed ID: 21615275
[TBL] [Abstract][Full Text] [Related]
3. Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes.
Patwardhan RS; Checker R; Sharma D; Kohli V; Priyadarsini KI; Sandur SK
Biochem Pharmacol; 2011 Sep; 82(6):642-57. PubMed ID: 21726543
[TBL] [Abstract][Full Text] [Related]
4. Curcumin and its synthetic analogue dimethoxycurcumin differentially modulates antioxidant status of normal human peripheral blood mononuclear cells.
Simon E; Aswini P; Sameer Kumar VB; Mankadath G
Free Radic Res; 2018 May; 52(5):583-591. PubMed ID: 29621898
[TBL] [Abstract][Full Text] [Related]
5. Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis.
Kunwar A; Jayakumar S; Srivastava AK; Priyadarsini KI
Arch Toxicol; 2012 Apr; 86(4):603-14. PubMed ID: 22119759
[TBL] [Abstract][Full Text] [Related]
6. Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits NO production, inducible NO synthase expression and NF-kappaB activation in RAW264.7 macrophages activated with LPS.
Pae HO; Jeong SO; Kim HS; Kim SH; Song YS; Kim SK; Chai KY; Chung HT
Mol Nutr Food Res; 2008 Sep; 52(9):1082-91. PubMed ID: 18481332
[TBL] [Abstract][Full Text] [Related]
7. Dimethoxycurcumin, a metabolically stable analogue of curcumin enhances the radiosensitivity of cancer cells: Possible involvement of ROS and thioredoxin reductase.
Jayakumar S; Patwardhan RS; Pal D; Sharma D; Sandur SK
Biochem Biophys Res Commun; 2016 Sep; 478(1):446-454. PubMed ID: 27381867
[TBL] [Abstract][Full Text] [Related]
8. Liposomes encapsulated dimethyl curcumin regulates dipeptidyl peptidase I activity, gelatinase release and cell cycle of spleen lymphocytes in-vivo to attenuate collagen induced arthritis in rats.
Sun Z; Wei T; Zhou X
Int Immunopharmacol; 2018 Dec; 65():511-521. PubMed ID: 30408628
[TBL] [Abstract][Full Text] [Related]
9. Interaction of a curcumin analogue dimethoxycurcumin with DNA.
Kunwar A; Simon E; Singh U; Chittela RK; Sharma D; Sandur SK; Priyadarsini IK
Chem Biol Drug Des; 2011 Apr; 77(4):281-7. PubMed ID: 21244640
[TBL] [Abstract][Full Text] [Related]
10. A review of therapeutic effects of curcumin.
Noorafshan A; Ashkani-Esfahani S
Curr Pharm Des; 2013; 19(11):2032-46. PubMed ID: 23116311
[TBL] [Abstract][Full Text] [Related]
11. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs).
Zhao C; Liu Z; Liang G
Curr Pharm Des; 2013; 19(11):2114-35. PubMed ID: 23116317
[TBL] [Abstract][Full Text] [Related]
12. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses.
Aggarwal BB; Deb L; Prasad S
Molecules; 2014 Dec; 20(1):185-205. PubMed ID: 25547723
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin.
Tamvakopoulos C; Dimas K; Sofianos ZD; Hatziantoniou S; Han Z; Liu ZL; Wyche JH; Pantazis P
Clin Cancer Res; 2007 Feb; 13(4):1269-77. PubMed ID: 17317839
[TBL] [Abstract][Full Text] [Related]
14. Dimethoxycurcumin reduces proliferation and induces apoptosis in renal tumor cells more efficiently than demethoxycurcumin and curcumin.
Zanetti TA; Biazi BI; Coatti GC; Baranoski A; Marques LA; Corveloni AC; Mantovani MS
Chem Biol Interact; 2021 Apr; 338():109410. PubMed ID: 33582110
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury.
Ashrafizadeh M; Ahmadi Z; Mohammadinejad R; Farkhondeh T; Samarghandian S
Curr Mol Med; 2020; 20(2):116-133. PubMed ID: 31622191
[TBL] [Abstract][Full Text] [Related]
16. Curcumin: the Indian solid gold.
Aggarwal BB; Sundaram C; Malani N; Ichikawa H
Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cells.
Hassan HE; Carlson S; Abdallah I; Buttolph T; Glass KC; Fandy TE
Pharm Res; 2015 Mar; 32(3):863-75. PubMed ID: 25186441
[TBL] [Abstract][Full Text] [Related]
18. Curcumin: New Insights into an Ancient Ingredient against Cancer.
Willenbacher E; Khan SZ; Mujica SCA; Trapani D; Hussain S; Wolf D; Willenbacher W; Spizzo G; Seeber A
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013694
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria as a target in the therapeutic properties of curcumin.
Trujillo J; Granados-Castro LF; Zazueta C; Andérica-Romero AC; Chirino YI; Pedraza-Chaverrà J
Arch Pharm (Weinheim); 2014 Dec; 347(12):873-84. PubMed ID: 25243820
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of epithelial transport and oxidative stress protection of nanoengineered curcumin derivative-cyclodextrin formulation for ocular delivery.
Maharjan P; Jin M; Kim D; Yang J; Maharjan A; Shin MC; Cho KH; Kim MS; Min KA
Arch Pharm Res; 2019 Oct; 42(10):909-925. PubMed ID: 31030375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
